Detalhe da pesquisa
1.
A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation.
Br J Haematol
; 169(1): 36-43, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572917